BioNTech Settles mRNA Patent Dispute with GSK and CureVac
BioNTech has reached a settlement in a three-year mRNA patent dispute with GSK and CureVac, a fellow German biotechnology firm. This settlement comes as BioNTech is in the process of…
Breaking News & Top Stories
BioNTech has reached a settlement in a three-year mRNA patent dispute with GSK and CureVac, a fellow German biotechnology firm. This settlement comes as BioNTech is in the process of…
Massachusetts Attorney General Andrea Campbell recently attended an attorneys general conference in Paris, funded by taxpayers. The trip, which ran from July 29 to August 3, 2024, incurred costs totaling…